Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Characterisation of Resistance Associated Variants (RAVs) to the newly approved anti-tuberculosis drugs Delamanid, Pretomanid, Bedaquiline, Clofazimine and Linezolid in isolates from a 2016/2017 Tanzanian Anti-Tuberculosis Drug Resistance Survey
This email address is used for sending the document.
